Drug
Zonegran
Zonegran: highest development phase Post-Market, developed by Eisai. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Zonegran NCT00165828 | Post-Market | Epilepsy |
Latest
No recent events.
Follow Zonegran on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.